Brickell Biotech Debt 2024

Brickell Biotech Aktienanalyse

What does Brickell Biotech do?

Brickell Biotech Inc is a biopharmaceutical company that focuses on the development and marketing of innovative dermatology products. The company was founded in 2009 and is headquartered in Boulder, Colorado (USA), with branches in California and Singapore. The history of Brickell Biotech dates back to the 1960s when the company was originally founded under the name Brickell Research Inc. Over the following decades, the company specialized in biological research and conducted important research that forms the basis for today's product development. Brickell Biotech's business model is based on the creation of new and innovative therapies for the treatment of various dermatological diseases. In recent years, the company has entered into a number of important partnerships to accelerate its product development and strengthen its position in the industry. Brickell Biotech operates in two main areas: pharmaceuticals and cosmetic products. In the pharmaceuticals area, the company has a number of promising therapies in the pipeline that target the treatment of skin cancer, psoriasis, and other dermatological conditions. The company's flagship product is Sofpironium Bromide, a potential treatment for hyperhidrosis (excessive sweating). In the cosmetic products area, the company has developed a range of skincare products tailored to the needs of people with sensitive, dry, or aging skin. These products include moisturizers, cleansers, and anti-aging products, all made from high-quality ingredients. Brickell Biotech works closely with the scientific community to explore the latest developments and innovations in dermatology and the cosmetics industry. The company has also established a strong presence in the medical and research sectors by collaborating closely with leading universities and medical institutions worldwide. Overall, Brickell Biotech is a promising company in the biopharmaceutical and cosmetics industry, specializing in the development of new and innovative therapies for the treatment of skin conditions. With a strong pipeline of products and a dedicated leadership team, the company is expected to continue growing and establish itself as an important player in the industry. Brickell Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Brickell Biotech's Debt Structure

Brickell Biotech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Brickell Biotech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Brickell Biotech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Brickell Biotech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Brickell Biotech stock

What is the debt of Brickell Biotech this year?

Brickell Biotech has a debt level of -8.68 USD this year.

What was the debt of Brickell Biotech compared to the previous year?

The debt of Brickell Biotech has increased by -67.71% compared to the previous year dropped.

What are the consequences of high debt for investors in Brickell Biotech?

High debt can pose a risk for investors of Brickell Biotech, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Brickell Biotech?

Low debt means that Brickell Biotech has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Brickell Biotech affect the company?

An increase in debt of Brickell Biotech can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Brickell Biotech affect the company?

A reduction in debt of Brickell Biotech can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Brickell Biotech?

Some factors that can influence the debt of Brickell Biotech include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Brickell Biotech so important for investors?

The debts of Brickell Biotech are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Brickell Biotech take to change the debt?

To change the debt, Brickell Biotech can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Brickell Biotech pay?

Over the past 12 months, Brickell Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brickell Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Brickell Biotech?

The current dividend yield of Brickell Biotech is .

When does Brickell Biotech pay dividends?

Brickell Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Brickell Biotech?

Brickell Biotech paid dividends every year for the past 0 years.

What is the dividend of Brickell Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Brickell Biotech located?

Brickell Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Brickell Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Brickell Biotech from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Brickell Biotech pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Brickell Biotech in the year 2023?

In the year 2023, Brickell Biotech distributed 0 USD as dividends.

In which currency does Brickell Biotech pay out the dividend?

The dividends of Brickell Biotech are distributed in USD.